34.26
price up icon0.06%   0.02
after-market Handel nachbörslich: 34.40 0.14 +0.41%
loading

Finanzdaten der Definium Therapeutics Inc-Aktie (DFTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Expenses
26.78%
75.08
59.22 47.58 45.67 40.90
Interest Income/Expense
0.96%
1.233
1.245 1.268 1.274 2.338
Operating Income/Loss
26.78%
-75.08
-59.22 -47.58 -45.67 -40.90
Net Income/Loss
106.21%
-158.99
-77.10 -50.44 -67.27 -42.74
Basic Average Shares
1.74%
110.68
108.79 - 85.89 85.35
Diluted Average Shares
1.74%
110.68
108.79 - 85.89 85.35
Basic Earnings Per Share
102.82%
-1.44
-0.71 - -0.78 -0.50
Diluted Earnings Per Share
102.82%
-1.44
-0.71 - -0.78 -0.50
$115.07
price up icon 1.41%
$73.87
price down icon 3.66%
$40.64
price up icon 2.63%
$52.79
price down icon 0.90%
$51.52
price up icon 2.59%
$74.53
price down icon 0.31%
Kapitalisierung:     |  Volumen (24h):